Monitoring viral mutations
Genomic surveillance is a critical tool for monitoring viral mutations that subsequently help current vaccines remain effective.
Read more about the work of the Seattle Flu Study, Nextstrain and CMAP Investigator Dr. Lea Starita in this recent Bloomberg Businessweek QuickTake documentary "Are We Prepared for the Next Pandemic?”
“My goal is to try to make this stuff a heck of a lot cheaper so that we can kind of perform this sort of surveillance without breaking the bank like we've been doing for the last couple of years.” Dr. Lea Starita